2019 Rheumatology group L-R: 1st row: Mehnaz Pervin, Dorothy Wang, Eric Morand, Wendy Zhu, Sarah Jones, Wendy Dankers, 2nd row: Hieu Nim, Md Hasnat, Megan Cristofaro, Jim Harris, 3rd row: Max Moraleda, Dinith Liyanage, 4th row: Fabien Vincent, Jacqueline Flynn
About the Rheumatology Group
The Rheumatology Group includes senior clinicians and laboratory researchers with backgrounds in rheumatology, kidney disease, immunology, clinical trials, lupus and arthritis.
YouTube video (2.37min). Prof Eric Morand talks about living with lupus and the impact of our research
Professor Eric Morand
Professor Eric Morand trained as a specialist rheumatologist in Melbourne and at the Royal National Hospital for Rheumatic Diseases, Bath, UK, gaining Fellowship of the Royal Australasian College of Physicians in 1992.
Professor Morand was awarded the triennial Parr Prize for research by the Australian Rheumatology Association (ARA) in 2001. He has been a member of the council of the ARA and chairman of the Research and Scientific programme committee of the ARA.
Find out more about Professor Eric Morand.
Meet the people leading the way in rheumatology research.
We principally study the role of glucocorticoids-induced molecules in the human diseases rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Glucocorticoids have broad-spectrum effects on immune-inflammatory activation and are widely used in the treatment of inflammatory diseases, but their use is complicated by significant toxicity owing to non-anti-inflammatory effects. Work includes clinico-pathological correlations using human samples, animal models of disease including novel gene knockout mice, and in vitro work on signal transduction pathways. It is our hypothesis that a greater understanding of the actions of glucocorticoids will lead to the development of new therapeutic agents for the treatment of inflammatory disease.
The Australian Lupus Registry is a collaboration between centres and institutes all over Australia to improve treatment and outcomes for people suffering from lupus.
We are also part of the Asia Pacific Lupus Colloboration (APLC), an international collaboration involving researchers and expert clinicians from 11 countries to improve the quality of care for lupus patients in the Asia Pacific region.